This coronavirus pandemic is the most contagious outbreak we’ve ever seen. It is ravaging health care systems and economies around the globe, and we are very likely only in the beginning stages.
The World Health Organization has warned that without a new vaccine, up to 60% of the planet’s population could be infected by coronavirus. And with its current fatality rate, it means that nearly 143 million people could die. That’s almost triple the number killed by Spanish Flu and more than both World Wars combined.
And while your physical health is paramount in this time of crisis, there is no reason to neglect your financial health.
Every time there is an outbreak of a new disease, certain companies see their stocks explode.
For instance, we saw 300% growth with Precigen (PGEN) during the Zika Virus outbreak of 2015, and Inovio Pharmaceuticals (INO) shot up 420% during the SARS pandemic. Those are some big gains, but they pale in comparison to Sarepta Therapeutics (SRPT), which skyrocketed 1,149% during a wave of Bird Flu outbreaks.
And those profits are nothing compared to what we could see in the very near future, thanks to this record-setting coronavirus pandemic. In fact, I believe this will be one of the most valuable investment opportunities of our lifetimes.
Right now, there’s no bigger opportunity to increase your wealth than investing in the right coronavirus stocks.
There are a number of companies seeking to create tests, cures and vaccines that will get us past this pandemic. In fact, there are over 80 clinical trials underway to find effective coronavirus treatments.
Some will inevitably flop. And whichever company or companies win the race for the cure are going to explode. But which companies will they be?
Thanks to the connections I’ve built over my decades-long career, I’m often the first to know about explosive opportunities like this. I know how you could turn as little as $100 into $55,400… $1,000 into $554,000…. or $2,000 into an incredible $1.1 million.
One of these opportunities shot up following a previous pandemic. Back in 2013, shares of the nano-biopharmaceutical company jumped from around $9 to a high over $150 a share — a gain of 1,557 % in a matter of months — on news of an Ebola vaccine.
Fast forward to 2020, and the company is back at it again. This time, it is using its now legendary expertise developing antiviral drugs based on its proprietary “bind-encapsulate-destroy” principles.
It is one of a few biopharma companies that possesses its own facilities to support all of its drug development activities from discovery, optimization, pre-clinical large-scale production, to clinical production of its drug candidates.
And as you can see in the chart below, the stock spiked recently on news of a vaccine project for coronavirus.
Shares have since pulled back, and this may represent an insane buying opportunity for traders with the foresight to get in before the next big spike.
Another potential gigantic opportunity for investors is a company working on designing a test for coronavirus.
Coronavirus has the ability to stay hidden and multiply in the throat and nose fluids of humans without causing the host to show any signs whatsoever of being infected. So not having enough effective tests is exactly what is causing the virus to spread so uncontrollably.
The company’s test kit employs proprietary technology to measure the virus count in human subjects in real time. The test is almost ready for prime time and has been submitted to the European Medicines Agency (the EU equivalent to the FDA) and should be available soon.
Given that it has one of the only certified tests on the market, it’s not surprising the stock has already started to move higher. However, it still remains around just $3 per share.
We are still in the first inning of what is shaping up to be a long and protracted global healthcare war of massive proportions.
The two companies I discussed could make early investors rich. Those who wait will be fighting for the scraps.
What’s crazy, though, is that they are not even my top stock picks that will benefit from this once-in-a-lifetime event. I recently put together a series of reports in which I detail all the extraordinary opportunities facing investors today.
If you’d like to know exactly which stocks I’d invest in, you can get all my reports here for a massive discount.
I recommend you act now, time is of the essence with these stocks. In a few days, it could be too late.
The James West Letter
This article is supplied courtesy of Wealthpress.com